Stericycle's high P/S ratio may be due to expectations of a revenue turnaround. However, with weak revenue growth and a higher industry growth forecast, the elevated P/S ratio may not be justified and could fall if revenue sentiment doesn't improve. Current prices may not be reasonable unless conditions significantly improve.
Repeated insider purchases of Stericycle, Inc.'s shares at near current price indicate optimism about the company's future. Despite no recent quarter insider trading, the holdings hint at alignment between insiders and shareholders, although insider ownership is not particularly high.
Stericycle's declining ROCE and capital employed may signify competitive challenges or deterioration of its business advantage, indicating that the company may have moved beyond its growth phase, causing investor concern.
Investors are let down by Stericycle's lack of profit and revenue growth. However, the company making progress amidst negative sentiment could offer an opportunity. Insiders buying shares is a good sign, yet revenue and earnings growth trends still hold more importance.
ステリサイクルに関するコメント
コラムTop upgrades and downgrades on 5/12
•$アルベマール(ALB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $285 (from $215)
• $アルコン(ALC.US)$ : Stephens Upgrades to Overweight from EqualWeight - PT $92 (from $86)
• $アトランティカ・サステナブル・インフラストラクチャー(AY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $33 (from $38)
• $クーパン(CPNG.US)$ : Citigroup Upgrades to Buy from Neutral - PT $15 (from $29)
• $89バイオ(ETNB.US)$ : Raymond James Upgrades to Strong Buy from Outp...
まだコメントはありません